SkinScreener 2.16.48

The incidence of skin cancer has been on the rise globally in recent years. It is estimated that the lifetime risk of developing skin cancer is around 20%. Early detection plays a crucial role in improving outcomes. Detecting skin cancer at an early stage significantly increases the chances of successful treatment. For this reason, a team comprising dermatologists and biomedical engineers has designed SkinScreener, a tool aimed at determining the individual risk of abnormal skin areas using an application, complementing routine dermatological checks.

• A clinical investigation conducted at the Medical University of Graz, involving over 1500 images of actual patients, has demonstrated SkinScreener's remarkable 95% accuracy rate in skin cancer detection.
• SkinScreener is a user-friendly application created and scientifically validated by a group of dermatologists, medical professionals, and biomedical engineers. This app allows for a rapid risk assessment of skin cancer concerning skin lesions such as moles, discolorations, and birthmarks.

Users can take a photo of the concerned skin area using their smartphone's camera. Subsequently, the image undergoes analysis through our scientifically proven neural network. The risk level for skin cancer is presented in a simple 3-color code (low, medium, high risk).

• SkinScreener can be downloaded free of charge with initial complimentary scans upon registration. Additional scans are available through subscription plans for 3 or 12 months or via single scan purchases.
• Prior to scanning, users must conduct a camera test to ensure proper functionality and image quality. The scan procedure follows the provided guidelines. The algorithm generates a skin cancer risk evaluation at the specified skin area as:

1. Green: LOW RISK
2. Yellow: MEDIUM RISK
3. Red: HIGH RISK

Following the risk assessment, users are encouraged to seek advice from a dermatologist for further evaluation to attain an accurate diagnosis. Individuals with a "MEDIUM RISK" or "HIGH RISK" rating are advised to consult a dermatologist promptly beyond regular preventive dermatological examinations. A specialist will confirm outcomes through additional expert assessments.

For cases with a LOW RISK evaluation, consistent monitoring of the affected skin lesion and rescanning every month is recommended.

Nevertheless, SkinScreener users should attend annual dermatological check-ups conducted by their dermatologist.

SkinScreener is classified as a Class I medical device (European Directive 93/42/EEC) and has been clinically validated through research at the Medical University of Graz.

The use of SkinScreener is intended for adult users with Fitzpatrick skin types ranging from I (ivory) to IV (light brown) and should not be employed on children.

We prioritize data security! Your data will solely reside on European servers adhering to the EU Data Protection Directive (GDPR). Images will be stored anonymously on our servers solely for improving our application and research purposes.

Indication: To evaluate skin lesions for potential visual signs of skin cancer using a three-tier classification (LOW RISK, MEDIUM RISK, HIGH RISK).

General terms and conditions

Privacy policy